5-HT2C receptor blockade reverses SSRI-associated basal ganglia dysfunction and potentiates therapeutic efficacy.
Mol Psychiatry
; 25(12): 3304-3321, 2020 12.
Article
in En
| MEDLINE
| ID: mdl-30120415
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Selective Serotonin Reuptake Inhibitors
/
Receptor, Serotonin, 5-HT2C
Type of study:
Risk_factors_studies
Limits:
Animals
Language:
En
Journal:
Mol Psychiatry
Journal subject:
BIOLOGIA MOLECULAR
/
PSIQUIATRIA
Year:
2020
Document type:
Article
Affiliation country: